Puma Biotechnology Announces Amendment To Neratinib Licensing Agreement With Pfizer
July 22, 2014 at 16:06 PM EDT
Puma Biotechnology, Inc. (NYSE: PBYI), a development stage biopharmaceutical company, announced an amendment to its licensing agreement ...